Brooks Laboratories Ltd
Brooks Laboratories Ltd (BROOKS) last traded at ₹61.5, a market capitalisation of ₹181 crore, on a P/E of 13.7. Over the past 52 weeks the stock has ranged between ₹36.3 and ₹164. Brooks Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹22.96 crore and net profit of ₹-1.79 crore. Brooks Laboratories Ltd’s annual general meeting is scheduled for 3 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Brooks Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Brooks Laboratories Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹22.96 cr, down 10.0% from ₹25.51 cr a year earlier. Net profit swung to a loss of ₹1.79 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 20.79 | 20.52 | 23.32 | 25.51 | 23.45 | 16.57 | 20.21 | 22.96 |
| Expenses | 24.2 | 22.02 | 24.58 | 22.38 | 20.93 | 15.84 | 19.53 | 24.3 |
| Operating profit | -3.41 | -1.5 | -1.26 | 3.13 | 2.52 | 0.73 | 0.68 | -1.34 |
| OPM % | -16.40% | -7.31% | -5.40% | 12.27% | 10.75% | 4.41% | 3.36% | -5.84% |
| Other income | 0.2 | 0.03 | 0.62 | 7.15 | 6.13 | 5.32 | 1.35 | 0.18 |
| Interest | 0.32 | 0.28 | 0.26 | 0.3 | 0.28 | 0.16 | 0.09 | 0.21 |
| Depreciation | 0.43 | 0.38 | 0.39 | 0.39 | 0.39 | 0.39 | 0.41 | 0.42 |
| Profit before tax | -3.96 | -2.13 | -1.29 | 9.59 | 7.98 | 5.5 | 1.53 | -1.79 |
| Tax % | 0.00% | 0.00% | 13.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | -3.96 | -2.13 | -1.46 | 9.58 | 7.98 | 5.5 | 1.52 | -1.79 |
| EPS (₹) | -1.51 | -0.81 | -0.50 | 3.25 | 2.71 | 1.87 | 0.52 | -0.61 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Brooks Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 77 | 91 | 63 | 79 | 83 | 86 | 83 |
| Operating profit | 1 | -14 | -30 | -18 | -8 | 7 | 3 |
| OPM % | 0.7% | -16% | -47% | -22% | -10% | 8% | 3.1% |
| Net profit | -19 | -19 | -31 | -20 | -10 | 25 | 13 |
| EPS (₹) | -7.40 | -4.31 | -7.97 | -7.46 | -3.38 | 8.34 | 4.49 |
TTM is the trailing twelve months to the most recent quarter.
Brooks Laboratories Ltd growth and returns
- 10 Years
- %
- 5 Years
- 2%
- 3 Years
- 11%
- TTM
- -8%
- 10 Years
- %
- 5 Years
- 27%
- 3 Years
- 47%
- TTM
- 551%
- 10 Years
- -3%
- 5 Years
- -13%
- 3 Years
- -14%
- 1 Year
- -56%
- 10 Years
- %
- 5 Years
- -9%
- 3 Years
- -2%
- Last Year
- 22%
Brooks Laboratories Ltd shareholding pattern
Promoters held 52.62% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 10.38%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 63.59% | 59.06% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% |
| FIIs | 0.02% | 0.01% | 0.05% | 0.00% | 0.01% | 0.09% | 0.17% | 0.00% |
| DIIs | 3.86% | 3.86% | 10.38% | 10.38% | 10.38% | 10.38% | 10.38% | 10.38% |
| Public | 32.53% | 37.08% | 36.95% | 37.00% | 37.00% | 36.91% | 36.84% | 37.00% |
| No. of shareholders | 11,282 | 10,521 | 10,537 | 10,317 | 10,078 | 10,532 | 10,741 | 11,161 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Brooks Laboratories Ltd’s AGM?
Brooks Laboratories Ltd’s annual general meeting is scheduled for 3 Sept 2026.
- AGM24th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Brooks Laboratories Ltd corporate filings
- Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Brooks Laboratories has released an addendum to the notice for its 24th Annual General…
Read the full analysis - Addendum To The Notice Of 24Th Annual General Meeting Of The Company.AGM/EGMlow impact
Cruxal's analysis: Brooks Laboratories Limited has issued an addendum to its 24th Annual General Meeting…
Read the full analysis - Addendum to the Notice of 24th Annual General Meeting of the Company.Otherslow impact
Cruxal's analysis: Brooks Laboratories has released an addendum to the notice for its 24th Annual General…
Read the full analysis - Intimation of Record date, E-Voting dates and Book Closure date.Corp. Actionlow impact
Cruxal's analysis: Brooks Laboratories has issued an intimation regarding the record date, book closure, and…
Read the full analysis - Newspaper publication dated 14th August 2026 of Unaudited Financial Results for the quarter ended 30th June 2026.Company Updatelow impact
Cruxal's analysis: Brooks Laboratories Limited has released its unaudited standalone and consolidated…
Read the full analysis - Outcome of Board Meeting held on Thursday, 13th August, 2026Board Meetinghigh impact
Cruxal's analysis: Brooks Laboratories Limited reported standalone revenue from operations of 22.96 crore…
Read the full analysis - Newspaper publication regarding 24th AGM of the Company to be held on 3rd September 2026.Company Updatelow impact
Cruxal's analysis: Brooks Laboratories Limited has issued a formal intimation regarding its 24th Annual…
Read the full analysis - Letter to the Shareholders-Annual Report for the FY 2025-26Company Updatelow impact
Cruxal's analysis: Brooks Laboratories Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Notice of 24th Annual General Meeting of the Company to be held on 3rd September 2026 through VC/OAVM.AGM/EGMlow impact
Cruxal's analysis: Brooks Laboratories Limited has issued a notice for its 24th Annual General Meeting (AGM)…
Read the full analysis - Pursuant to Regulation 34 read with Regulation 30 of SEBI Listing Regulations, we are enclosing herewith the following: 1. Notice of the AGM.2. Annual Report for the Financial Year 2025-26.Othershigh impact
Cruxal's analysis: Brooks Laboratories Limited reported a strong financial performance for FY 2025-26, with…
Read the full analysis - Newspaper Advertisement - Intimation of 24th Annual General Meeting of the Company through VC/OAVM.Company Updatelow impact
Cruxal's analysis: Brooks Laboratories Ltd has issued a newspaper advertisement intimating the convening of…
Read the full analysis - Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve and take on record the ....Board Meetinglow impact
Cruxal's analysis: Brooks Laboratories Limited has formally intimated the stock exchanges regarding a Board…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Brooks Laboratories Ltd
Cruxal reads every Brooks Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.